Blog
RSS FeedPosted by Michael Wonder on 25 May 2023
Australians battling with prostate cancer to benefit from new PBS listing
25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine ...
Posted by Michael Wonder on 24 May 2023
PBAC Public Summary Document - May 2023
24 May 2023 - The Public Summary Document of the PBAC's consideration of the interim report of the post-market review of ...
Posted by Michael Wonder on 24 May 2023
New life changing treatment for dwarfism added to PBS
24 May 2023 - Children born with the most common form of dwarfism will have access to a new life ...
Posted by Michael Wonder on 24 May 2023
Revolutionising MS treatment: new form of Tysabri recommended for PBS listing
24 May 2023 - The PBAC has recommended the listing of natalizumab (Tysabri) pre-filled syringe for subcutaneous injection on the PBS. ...
Posted by Michael Wonder on 21 May 2023
Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia.
18 May 2023 - This study aimed to assess whether there have been changes in the quality of clinical evidence ...
Posted by Michael Wonder on 16 May 2023
RACGP welcomes asthma puffer decision saving Aussie families time and money
15 May 2023 - The Royal Australian College of GPs (RACGP) has welcomed the PBAC's decision to remove limitations requiring ...
Posted by Michael Wonder on 14 May 2023
Pharmacy Guild rebuked over scare campaign on medicine shortages
15 May 2023 - A long-time chair of the government’s independent pharmaceutical advisory body has rebuked the powerful pharmacy lobby ...
Posted by Michael Wonder on 13 May 2023
PBAC dismisses Pharmacy Guild concerns on 60 day dispensing
12 May 2023 - The chair of the PBAC has dismissed concerns that 60 day dispensing will cause medicine shortages, ...
Posted by Michael Wonder on 12 May 2023
Public Consultation: draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP
12 May 2023 - Consultation on the draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...
Posted by Michael Wonder on 12 May 2023
PBAC backs ongoing access to low-dose asthma puffer for Aussie kids
12 May 2023 - The independent, expert group advising the Australian Government on PBS medications has reviewed its recommendation to put ...
Posted by Michael Wonder on 12 May 2023
Outcome in relation to fluticasone propionate – May 2023 PBAC intracycle meeting
12 May 2023 - The outcome for fluticasone propionate from the May 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 11 May 2023
More medicine, for less
11 May 2023 - The Australian Government is making hundreds of medicines cheaper by allowing millions of Australians to buy two ...
Posted by Michael Wonder on 11 May 2023
May 2023 updates from the Health Technology Assessment Policy and Methods Review Reference Committee
11 May 2023 - Information regarding the experts in HTA to support the HTA Review is now available. ...
Posted by Michael Wonder on 10 May 2023
Reforming opioid dependence treatment access
10 May 2023 - In the 2023-24 Budget, the Australian Government committed $377.3 million over 4 years from 2023–24 (and $98.4 ...
Posted by Michael Wonder on 10 May 2023
Recommendations made out-of-session by the PBAC between March 2023 and July 2023 meetings
10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available. ...